z-logo
Premium
Molecular spectrum of α‐thalassemia in the Iranian population of Hormozgan: Three novel point mutation defects
Author(s) -
Harteveld C.L.,
Yavarian M.,
Zorai A.,
Quakkelaar E.D.,
van Delft P.,
Giordano P.C.
Publication year - 2003
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.10385
Subject(s) - frameshift mutation , genetics , thalassemia , point mutation , exon , mutation , population , allele , biology , microbiology and biotechnology , gene , medicine , environmental health
We describe the molecular spectrum of α‐thalassemia mutations in a population sample of newborns in the South‐Iranian province of Hormozgan. Out of 660 randomly collected blood samples 218 (33%) had visibly elevated Hb Bart's. DNA was extracted from 78 samples out of this selection (n = 156), of which 114 alleles were found to carry an α‐thalassemia defect. Besides the common −α 3.7 (79.1%), −α 4.2 (1.7%), and α ‐5nt α alleles (4.3%), three novel nondeletional α‐thalassemia mutations were found; the α 2 cd19 (‐G) frameshift mutation (12.2%), the α 1 IVS1‐148(A→G) (0.9%) affecting the splice acceptor site consensus sequence and the cd14 (TGG→TAG) (0.9%), which creates a premature stop codon in the first exon of the α 1 ‐gene. A fourth mutation in the α 1 ‐gene, the IVS1‐38 (C→T) (0.9%) of undetermined effect, was found in an individual heterozygous for the α 2 cd19(‐G) mutation. Am. J. Hematol. 74:99–103, 2003. © 2003 Wiley‐Liss, Ins.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom